Episode 245: Three studies you need to know about – so get a PREMIUM membership!
In episode 245, Mike and James PREMIUM the listeners with talk about three new studies. Aleglitazar a new drug that was supposed to help people with type 2 diabetes, how best to use delayed antibiotic prescribing and a trial that answers the question about population screening for high cardiovascular risk patients.
Show notes
1) AleCardio – aleglitazar
2) Delayed prescribing of antibiotics
3) INTER99 – Population screening and lifestyle counsellng
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
